192 related articles for article (PubMed ID: 14503112)
1. Association of hyperglycemia and markers of hepatic dysfunction with dextrose infusion rates in Korean patients receiving total parenteral nutrition.
Kim H; Son E; Kim J; Choi K; Kim C; Shin W; Suh O
Am J Health Syst Pharm; 2003 Sep; 60(17):1760-6. PubMed ID: 14503112
[TBL] [Abstract][Full Text] [Related]
2. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose.
Rosmarin DK; Wardlaw GM; Mirtallo J
Nutr Clin Pract; 1996 Aug; 11(4):151-6. PubMed ID: 9070016
[TBL] [Abstract][Full Text] [Related]
3. Hypercholesterolemia and hypertriglyceridemia as risk factors of liver dysfunction in children with inflammation receiving total parenteral nutrition.
Golucci APBS; Morcillo AM; Hortencio TDR; Ribeiro AF; Nogueira RJN
Clin Nutr ESPEN; 2018 Feb; 23():148-155. PubMed ID: 29460791
[TBL] [Abstract][Full Text] [Related]
4. Hepatobiliary complications in healthy, intra-abdominally infected, and high-output fistula rats receiving total parenteral nutrition.
Mok KT
JPEN J Parenter Enteral Nutr; 1993; 17(5):449-53. PubMed ID: 8289412
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of metabolic complications of conventional total parenteral nutrition. A prospective randomized study.
Meguid MM; Akahoshi MP; Jeffers S; Hayashi RJ; Hammond WG
Arch Surg; 1984 Nov; 119(11):1294-8. PubMed ID: 6437372
[TBL] [Abstract][Full Text] [Related]
6. Similar liver function abnormalities occur in patients receiving glucose-based and lipid-based parenteral nutrition.
Wagner WH; Lowry AC; Silberman H
Am J Gastroenterol; 1983 Apr; 78(4):199-202. PubMed ID: 6404158
[TBL] [Abstract][Full Text] [Related]
7. Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease.
Bengoa JM; Hanauer SB; Sitrin MD; Baker AL; Rosenberg IH
Hepatology; 1985; 5(1):79-84. PubMed ID: 3917969
[TBL] [Abstract][Full Text] [Related]
8. Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation.
Sheean PM; Freels SA; Helton WS; Braunschweig CA
Biol Blood Marrow Transplant; 2006 Jun; 12(6):656-64. PubMed ID: 16737939
[TBL] [Abstract][Full Text] [Related]
9. Liver function tests in patients receiving parenteral nutrition.
Clarke PJ; Ball MJ; Kettlewell MG
JPEN J Parenter Enteral Nutr; 1991; 15(1):54-9. PubMed ID: 1901108
[TBL] [Abstract][Full Text] [Related]
10. The incidence and impact of dextrose dose on hyperglycemia from parenteral nutrition (PN) exposure in hematopoietic stem cell transplant (HSCT) recipients.
Sheean P; Braunschweig C
JPEN J Parenter Enteral Nutr; 2006; 30(4):345-50. PubMed ID: 16804133
[TBL] [Abstract][Full Text] [Related]
11. Liver test alterations with total parenteral nutrition and nutritional status.
Leaseburge LA; Winn NJ; Schloerb PR
JPEN J Parenter Enteral Nutr; 1992; 16(4):348-52. PubMed ID: 1640633
[TBL] [Abstract][Full Text] [Related]
12. Intravenous and intrapulmonary administration of honey solution to healthy sheep: effects on blood sugar, renal and liver function tests, bone marrow function, lipid profile, and carbon tetrachloride-induced liver injury.
Al-Waili NS
J Med Food; 2003; 6(3):231-47. PubMed ID: 14585190
[TBL] [Abstract][Full Text] [Related]
13. Metronidazole prevention of serum liver enzyme abnormalities during total parenteral nutrition.
Lambert JR; Thomas SM
JPEN J Parenter Enteral Nutr; 1985; 9(4):501-3. PubMed ID: 2863398
[TBL] [Abstract][Full Text] [Related]
14. Liver function values in adults receiving total parenteral nutrition.
Lindor KD; Fleming CR; Abrams A; Hirschkorn MA
JAMA; 1979 Jun; 241(22):2398-400. PubMed ID: 108412
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Risk Factors of Total Parenteral Nutrition Induced Hyperglycemia at a Single Institution: Retrospective Study.
Alchaer M; Khasawneh R; Heuberger R; Hewlings S
Metab Syndr Relat Disord; 2020 Jun; 18(5):267-273. PubMed ID: 32250718
[No Abstract] [Full Text] [Related]
16. Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels.
Sax HC; Talamini MA; Brackett K; Fischer JE
Surgery; 1986 Oct; 100(4):697-704. PubMed ID: 3094186
[TBL] [Abstract][Full Text] [Related]
17. Postoperative total parenteral nutrition in patients with liver disorders.
Okuno M; Nagayama M; Takai T; Rai A; Nakao S; Kamino K; Umeyama K
J Surg Res; 1985 Aug; 39(2):93-102. PubMed ID: 3927062
[TBL] [Abstract][Full Text] [Related]
18. The enhanced effect of parenteral nutrition on hepatotoxicity.
Denno R; Rounds JD; Faris R; Holejko LB; Wilmore DW
Nutrition; 1996 Jan; 12(1):30-5. PubMed ID: 8838833
[TBL] [Abstract][Full Text] [Related]
19. Serum hepatic enzyme and bilirubin elevations during parenteral nutrition.
Grant JP; Cox CE; Kleinman LM; Maher MM; Pittman MA; Tangrea JA; Brown JH; Gross E; Beazley RM; Jones RS
Surg Gynecol Obstet; 1977 Oct; 145(4):573-80. PubMed ID: 408935
[TBL] [Abstract][Full Text] [Related]
20. Liver dysfunction and energy source: results of a randomized clinical trial.
Buchmiller CE; Kleiman-Wexler RL; Ephgrave KS; Booth B; Hensley CE
JPEN J Parenter Enteral Nutr; 1993; 17(4):301-6. PubMed ID: 8271352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
